Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 May;71(5):1514–1518. doi: 10.1172/JCI110907

Plasma somatostatin 28 increases in response to feeding in man.

K S Polonsky, S E Shoelson, H M Docherty
PMCID: PMC437018  PMID: 6133883

Abstract

Tissue somatostatin-like immunoreactivity (SLI) consists of a number of molecular species including the cyclic tetradecapeptide or SRIF, an N-terminally extended form of SRIF termed somatostatin-28, as well as larger precursor peptides. The function and nature of circulating SLI is not well understood. In this report, we describe techniques for the definition of the components of plasma SLI in normal human plasma. Plasma SLI measured after gel filtration on Bio-gel P-6 columns was found to consist of from 1-3 peaks. The void volume peak was present in greatest concentration (34.2 +/- 8.9 pg/ml) and did not increase in response to a mixed meal. Very low levels of two additional peaks of SLI activity were found. To further characterize these peaks, 10-ml plasma samples were extracted and concentrated on octadecylsilyl silica (C-18) cartridges with subsequent fractionation on Bio-gel P-6 columns. The two peaks that coeluted with synthetic SRIF and S-28 markers, respectively, were present in concentrations of 5.4 +/- 1.4 and 4.8 +/- 1.9 pg/ml in fasting plasma. In response to a mixed meal, the SLI14 peak doubled (12.9 +/- 2.4 pg/ml) while the SLI28 peak increased to 29.9 +/- 7.2 pg/ml at 120 min. These results provide evidence that S-28 circulates in human plasma and its increase after feeding is consistent with a possible biological role for this peptide.

Full text

PDF
1514

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benoit R., Böhlen P., Ling N., Briskin A., Esch F., Brazeau P., Ying S. Y., Guillemin R. Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proc Natl Acad Sci U S A. 1982 Feb;79(3):917–921. doi: 10.1073/pnas.79.3.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brazeau P., Ling N., Esch F., Böhlen P., Benoit R., Guillemin R. High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regul Pept. 1981 Jan;1(4):255–264. doi: 10.1016/0167-0115(81)90048-3. [DOI] [PubMed] [Google Scholar]
  3. Harris V., Conlon J. M., Srikant C. B., McCorkle K., Schusdziarra V., Ipp E., Unger R. H. Measurements of somatostatin-like immunoreactivity in plasma. Clin Chim Acta. 1978 Jul 15;87(2):275–283. doi: 10.1016/0009-8981(78)90348-0. [DOI] [PubMed] [Google Scholar]
  4. Kronheim S., Berelowitz M., Pimstone B. L. The characterization of somatostatin-like immunoreactivity in human serum. Diabetes. 1978 May;27(5):523–529. doi: 10.2337/diab.27.5.523. [DOI] [PubMed] [Google Scholar]
  5. Lundqvist G., Gustavsson S., Elde R., Arimura A. A radioimmunoabsorbent assay for plasma somatostatin. Clin Chim Acta. 1980 Feb 28;101(2-3):183–191. doi: 10.1016/0009-8981(80)90243-0. [DOI] [PubMed] [Google Scholar]
  6. Mackes K., Itoh M., Greene K., Gerich J. Radioimmunoassay of human plasma somatostatin. Diabetes. 1981 Sep;30(9):728–734. doi: 10.2337/diab.30.9.728. [DOI] [PubMed] [Google Scholar]
  7. Patel Y. C., Reichlin S. Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat. Endocrinology. 1978 Feb;102(2):523–530. doi: 10.1210/endo-102-2-523. [DOI] [PubMed] [Google Scholar]
  8. Patel Y. C., Wheatley T., Ning C. Multiple forms of immunoreactive somatostatin: comparison of distribution in neural and nonneural tissues and portal plasma of the rat. Endocrinology. 1981 Dec;109(6):1943–1949. doi: 10.1210/endo-109-6-1943. [DOI] [PubMed] [Google Scholar]
  9. Polonsky K., Jaspan J., Berelowitz M., Pugh W., Moossa A., Ling N. The in vivo metabolism of somatostatin 28: possible relationship between diminished metabolism and enhanced biological action. Endocrinology. 1982 Nov;111(5):1698–1703. doi: 10.1210/endo-111-5-1698. [DOI] [PubMed] [Google Scholar]
  10. Pradayrol L., Chayvialle J. A., Carlquist M., Mutt V. Isolation of a porcine intestinal peptide with C-terminal somatostatin. Biochem Biophys Res Commun. 1978 Nov 29;85(2):701–708. doi: 10.1016/0006-291x(78)91218-4. [DOI] [PubMed] [Google Scholar]
  11. Shoelson S., Polonsky K., Docherty H., Jaspan J., Rubenstein A. Evidence for the presence of somatostatin 28 in plasma. Diabetes. 1982 May;31(5 Pt 1):474–477. doi: 10.2337/diab.31.5.474. [DOI] [PubMed] [Google Scholar]
  12. Srikant C. B., Patel Y. C. Receptor binding of somatostatin-28 is tissue specific. Nature. 1981 Nov 19;294(5838):259–260. doi: 10.1038/294259a0. [DOI] [PubMed] [Google Scholar]
  13. Vinik A. I., Levitt N. S., Pimstone B. L., Wagner L. Peripheral plasma somatostatin-like immunoreactive responses to insulin hypoglycemia and a mixed meal in healthy subjects and in noninsulin-dependent maturity-onset diabetics. J Clin Endocrinol Metab. 1981 Feb;52(2):330–337. doi: 10.1210/jcem-52-2-330. [DOI] [PubMed] [Google Scholar]
  14. Zingg H. H., Patel Y. C. Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture. J Clin Invest. 1982 Nov;70(5):1101–1109. doi: 10.1172/JCI110698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Zyznar E. S., Pietri A. O., Harris V., Unger R. H. Evidence for the hormonal status of somatostatin in man. Diabetes. 1981 Oct;30(10):883–886. doi: 10.2337/diab.30.10.883. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES